Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 5
2007 3
2008 3
2009 4
2010 3
2013 3
2014 6
2015 6
2017 1
2018 6
2019 3
2020 2
2021 5
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.
Birtas Atesoglu E, Gulbas Z, Uzay A, Ozcan M, Ozkalemkas F, Dal MS, Kalyon H, Akay OM, Deveci B, Bekoz H, Sevindik OG, Toptas T, Yilmaz F, Koyun D, Alkis N, Alacacioglu I, Sonmez M, Yavasoglu I, Tombak A, Mehtap O, Kurnaz F, Yuce OK, Karakus V, Turgut M, Kurekci DD, Ayer M, Keklik M, Buyuktas D, Ozbalak M, Ferhanoglu B. Birtas Atesoglu E, et al. Among authors: alacacioglu i. Hematol Oncol. 2023 Oct;41(4):663-673. doi: 10.1002/hon.3174. Epub 2023 May 22. Hematol Oncol. 2023. PMID: 37211991
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma.
Beksac M, Aydin Y, Goker H, Turgut M, Besisik SK, Cagirgan S, Tuglular T, Vural F, Yagci M, Alacacioglu I, Aytan P, Goksoy HS, Gulbas Z, Gunes AK, Gurkan E, Hacioglu SK, Karti SS, Kaynar L, Ozdogu H, Paydas S, Solmaz S, Sonmez M, Tekgunduz E, Yildirim R, Ilhan O. Beksac M, et al. Among authors: alacacioglu i. Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):e474-e484. doi: 10.1016/j.clml.2020.02.017. Epub 2020 Mar 7. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32482539 Free article. Review.
Bortezomib-induced skin lesion.
Ozcan MA, Alacacioglu I, Piskin O, Lebe B, Turgut N, Ceneli S, Demirkan F, Ozsan GH, Undar B. Ozcan MA, et al. Among authors: alacacioglu i. Acta Haematol. 2006;116(3):226-7. doi: 10.1159/000094689. Acta Haematol. 2006. PMID: 17016047 No abstract available.
Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma.
Esmeray Sönmez E, Hatipoğlu T, Kurşun D, Hu X, Akman B, Yuan H, Erşen Danyeli A, Alacacıoğlu İ, Özkal S, Olgun A, Erdağ TK, You H, Küçük C. Esmeray Sönmez E, et al. Among authors: alacacioglu i. Cells. 2022 Oct 27;11(21):3394. doi: 10.3390/cells11213394. Cells. 2022. PMID: 36359790 Free PMC article.
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
Solmaz S, Uzun O, Acar C, Sevindik OG, Piskin O, Ozsan HG, Demirkan F, Undar B, Alacacioglu A, Ozcan MA, Alacacioglu I. Solmaz S, et al. Among authors: alacacioglu i. J Lab Physicians. 2018 Oct-Dec;10(4):363-369. doi: 10.4103/JLP.JLP_36_18. J Lab Physicians. 2018. PMID: 30498304 Free PMC article.
Subclinical hypercortisolism among polycythemia vera patients.
Bilgir O, Kebapcilar L, Alacacioglu I, Bilgir F, Yildiz Y, Yuksel A, Sari I. Bilgir O, et al. Among authors: alacacioglu i. Intern Med. 2010;49(13):1277-80. doi: 10.2169/internalmedicine.49.2763. Epub 2010 Jul 1. Intern Med. 2010. PMID: 20606359 Free article.
IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort.
Sevindik OG, Mersin S, Katgi A, Tunali S, Solmaz SM, Acar C, Alacacioglu I, Piskin O, Ozcan MA, Demirkan F, Undar B, Ozsan GH. Sevindik OG, et al. Among authors: alacacioglu i. Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):e101-4. doi: 10.1016/j.clml.2015.02.004. Epub 2015 Feb 11. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25790738
56 results